Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Bacteriology|November 1, 1987
Changes in peptidoglycan composition and penicillin-binding proteins in slowly growing Escherichia coliE Tuomanen, R Cozens
Journal of General Microbiology|May 1, 1986
The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growthE Tuomanen, R Cozens, W Tosch, et al.
European Journal of Biochemistry|July 1, 1992
Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factorsE McGlynn, M Becker, H Mett, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2000
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional stateF De Jaeghere, E Allémann, F Kubel, et al.
Journal of Pharmaceutical Sciences|December 1, 1995
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to miceJ C Leroux, R Cozens, J L Roesel, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailabilityA Fässler, G Bold, H G Capraro, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1993
CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activityE Alteri, G Bold, R Cozens, et al.
Archiv Der Pharmazie|June 1, 1996
Synthesis of potent and orally active HIV-protease inhibitorsH G Capraro, G Bold, A Fässler, et al.
Journal of the National Cancer Institute|October 19, 2000
Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571C Gambacorti-Passerini, R Barni, P le Coutre, et al.
Schweizerische Medizinische Wochenschrift|October 26, 1996
Profile of CGP 61755: a novel and potent HIV-1 protease inhibitor that shows enhanced anti-HIV activity when combined with other antiretroviral agents in vitroJ K Lazdins, G Bold, H G Capraro, et al.
Pageof 2